ArticleFrontiers in oncology2022
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer.
Muhamad Ansar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it